T
0.663
-0.05 (-7.18%)
| Penutupan Terdahulu | 0.714 |
| Buka | 0.696 |
| Jumlah Dagangan | 17,147,602 |
| Purata Dagangan (3B) | 42,963,533 |
| Modal Pasaran | 618,943,872 |
| Harga / Jualan (P/S) | 0.450 |
| Harga / Buku (P/B) | 0.160 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 8 Apr 2025 |
| Margin Keuntungan | -114.40% |
| Margin Operasi (TTM) | -16.76% |
| EPS Cair (TTM) | -1.10 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -1.40% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 12.73% |
| Nisbah Semasa (MRQ) | 2.62 |
| Aliran Tunai Operasi (OCF TTM) | -51.09 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 26.37 M |
| Pulangan Atas Aset (ROA TTM) | -1.63% |
| Pulangan Atas Ekuiti (ROE TTM) | -30.73% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Menurun | Bercampur |
| Drug Manufacturers - Specialty & Generic (Global) | Menurun | Bercampur | |
| Stok | Tilray Brands, Inc. | Menurun | Menurun |
AISkor Stockmoo
-0.4
| Konsensus Penganalisis | -0.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | -1.0 |
| Osilator Teknikal | -0.5 |
| Purata | -0.38 |
|
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 0.60% |
| % Dimiliki oleh Institusi | 10.90% |
| Julat 52 Minggu | ||
| Median | 1.00 (50.90%) | |
| Jumlah | 1 Pegang | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Piper Sandler | 09 Apr 2025 | 1.00 (50.90%) | Pegang | 0.530 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |